They are not authorized as prescription drugs, and their sale for human use is typically restricted
However, the GSH level in group 3 was recorded as 16.330.50 M/g tissue against 11.840.43 M/g tissue of group 1
Die vorlufigen Ergebnisse bei 30 Patienten zeigten eine Verbesserung des ECCA-Narbenscores um 42 % nach drei Microneedling-Sitzungen in Kombination mit GHK-Cu + PRP, gegenber 28 % mit PRP allein
It is known that the CV protection effect of GLP-1RAs have been proven through eight large-scale clinical studies, including Evaluation of LIXisenatide in Acute coronary syndrome (ELIXA) [66], LEADER [44], Semaglutide Unabated Sustainability in Treatment of Type 2 Diabetes (SUSTAIN)-6 [67], Exenatide Study of Cardiovascular Event Lowering (EXSCEL) [68], Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes) [69], Researching Cardiovascular Events with a Weekly INcretin in Diabetes (REWIND) [70], Peptide Innovation for Early Diabetes Treatment (PIONEER) 6 [67,71], and AMPLITUDE-O [51]
